White House Eyes FDA for AI with Dean Ball

Lawfare explores proposals for an "FDA for AI" at the White House, featuring insights from Dean Ball on scaling laws and rapid response mechanisms. This push signals Washington's growing itch to regulate artificial intelligence like a drug agency, potentially stifling innovation with bureaucratic red tape. Conservatives rightly worry this hands more power to unelected officials, threatening the free-market dynamism that drives AI breakthroughs. Read more about this...